Drug Profile
Plasma-derived human butyrylcholinesterase - Baxter Healthcare Corporation/DynPort Vaccine Company LLC
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Baxter Healthcare Corporation; DynPort Vaccine Company LLC
- Developer Baxter Healthcare Corporation; DynPort Vaccine Company
- Class Antidotes; Butyrates; Cholinesterases
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Poisoning
Most Recent Events
- 07 Apr 2008 Preclinical trials in Poisoning in USA (IM)